In vivo: Nodularin-R Enhances Abirate... - Fight Prostate Ca...

Fight Prostate Cancer

2,956 members1,313 posts

In vivo: Nodularin-R Enhances Abiraterone's Effectiveness Against Castration-Resistant Prostate Cancer

Maxone73 profile image
1 Reply

another door opens, hopefully a good one…

Researchers found that high expression of the PPP1CA gene is linked to a worse prognosis for patients. They discovered that silencing PPP1CA made cancer cells more susceptible to abiraterone, while overexpressing it had the opposite effect. This suggests that PPP1CA plays a crucial role in protecting cancer cells from abiraterone's effects. The study also identified nodularin-R, a natural product, as a potential inhibitor of PPP1CA. Combining nodularin-R with abiraterone resulted in synergistic inhibition of resistant cancer cells both in vitro and in vivo, indicating that nodularin-R might help overcome abiraterone resistance in CRPC.

prostatewarriors.com/2024/1...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...
1 Reply
Shams_Vjean profile image
Shams_Vjean

Nice find by these researchers. Hopefully there are less toxic natural substances which can provide the same or better results. Knowing what the target gene expressions are is an important first step.

Imagine how many who progressed on Abiraterone could benefit from a solution like this! Thanks for sharing this, Max!

Not what you're looking for?

You may also like...

Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy

New paper from Spain [1]. "... we will review those strategies and drugs that are able to...
pca2004 profile image

Phase 3 trial: 177Lu-DOTA-rosopatamab (TLX591) for patients with PSMA expressing metastatic castration-resistant prostate cancer

Doctors in Perth, Australia are leading a Phase 3 clinical trial called ProstACT GLOBAL, which is...
Maxone73 profile image

FDA grants accelerated approval to rucaparib for BRCA-mutated metastatic castration-resistant prostate cancer

From several day ago. A new treatment tool for mCRPC patients with BRCA mutations. From the FDA:...
cujoe profile image

Developments in the Continued Search for a Prostate Cancer Vaccine...

Greetings FPC members, As some of you know, I believe that the development of a vaccine or vaccines...
NPfisherman profile image

Oxidant…or antioxidant? Interesting paper: oral pro oxidant kills prostate cancer cells in VIVO

of course prostate cancer is not our only enemy, so I would not ban antioxidants at all, but one...
Maxone73 profile image